Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
The current price of ABT is $88.18 USD — it has decreased by -1.64% in the past 24 hours. Watch Abbott Laboratories stock price performance more closely on the chart.
What is Abbott Laboratories stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Abbott Laboratories stocks are traded under the ticker ABT.
Is Abbott Laboratories stock price growing?▼
ABT stock has fallen by -2.56% compared to the previous week, the month change is a +4.39% rise, over the last year Abbott Laboratories has showed a -34.98% decrease.
What is Abbott Laboratories market cap?▼
Today Abbott Laboratories has the market capitalization of 153.23B
When is the next Abbott Laboratories earnings date?▼
Abbott Laboratories is going to release the next earnings report on July 16, 2026.
What were Abbott Laboratories earnings last quarter?▼
ABT earnings for the last quarter are 1.15 USD per share, whereas the estimation was 1.14 USD resulting in a +0.47% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Abbott Laboratories revenue for the last year?▼
Abbott Laboratories revenue for the last year amounts to 88.66B USD.
What is Abbott Laboratories net income for the last year?▼
ABT net income for the last year is 13.05B USD.
Does Abbott Laboratories pay dividends?▼
Yes, ABT dividends are paid quarterly. The last dividend per share was 0.63 USD. As of today, Dividend Yield (FWD)% is 2.86%.
How many employees does Abbott Laboratories have?▼
As of June 15, 2026, the company has 114,000 employees.
In which sector is Abbott Laboratories located?▼
Abbott Laboratories operates in the Health & Wellness sector.
When did Abbott Laboratories complete a stock split?▼
The last stock split for Abbott Laboratories was on June 01, 1998 with a ratio of 2:1.
Where is Abbott Laboratories headquartered?▼
Abbott Laboratories is headquartered in Abbott Park, United States.